MedTrace Logo

Research on Sleep and Emotion Testing of Tea Theanine Casein Hydrolysate Pressed Candy

NCT07207252 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 171

Last updated 2025-10-03

No results posted yet for this study

Summary

The study evaluates the improvement of sleep, emotion, and skin by standardizing the use of the blend (Tea Theanine Casein Hydrolysate Pressed Candy, whose active ingredients include Tea Theanine, Casein Hydrolysate, and Saffron Extract).

This is a randomized, double-blind trial for Chinese people aged 20-55. The change of sleep, emotion, skin, and other related indicators of 90 participants after taking Tea Theanine Casein Hydrolysate Pressed Candy, whose active ingredients include tea theanine, casein hydrolysate, and saffron extract, was evaluated through a 28 days product placement test (sub study 1), and the emotional change of 70 participants after taking Tea Theanine Casein Hydrolysate Pressed Candy was evaluated through an EEG test (sub study 2).

Participants who meet the inclusion criteria were randomly assigned to use the experimental product or the placebo control. In sub study 1, 90 participants completed a 7-day baseline period, a 28-day testing period (T1d, T7d, and T28d). In sub study 2, 71 participants completed a single on-site test.

Conditions

  • Mild to Moderate Sleep Disorder
  • Pressure

Interventions

DIETARY_SUPPLEMENT

Tea Theanine Casein Hydrolysate Pressed Candy

Take 4 candies once a day. It is recommended to consume it one hour before bedtime.

DIETARY_SUPPLEMENT

Pressed Candy

Take 4 candies once a day.

Sponsors & Collaborators

  • Nu Skin Enterprises

    collaborator INDUSTRY

  • ChinaNorm

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-28
Primary Completion
2024-12-05
Completion
2024-12-05

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07207252 on ClinicalTrials.gov